Worldwide revenue of $58.9 million – an increase of 13.7% year over year U.S. revenue of $47.2 million – an increase of 15.5% year over year International revenue of $11.7 million – an increase of 7.0% year over year July 30, 2019 04:02 PM Eastern Daylight Time MASON, Ohio–(BUSINESS WIRE)–AtriCure, […]
Other News
Canon Medical Showcased the Alphenix Platform at Premier Inc.’s Annual Breakthroughs Conference
TUSTIN, Calif.–(BUSINESS WIRE)–The Alphenix™ platform is one of the medical innovations that was showcased in front of thousands of healthcare providers at Premier Inc.’s 2019 Breakthroughs Conference and Exhibition on June 18. Canon Medical’s Alphenix family of interventional systems was debuted during the conference’s 11th annual Innovation Celebration, an event recognizing advancements in healthcare and highlighting suppliers […]
PhysIQ Inc. Receives FDA Clearance of Continuous Ambulatory Respiration Rate Algorithm Enabling Artificial Intelligence-based Analytics for Biopharma Companies and Payers
FDA 510(k) cleared Respiration Rate analytic adds to physIQ’s growing portfolio of FDA 510(k) algorithms Clearance allows physIQ to power its higher-level AI analytics with validated vital sign inputs PhysIQ’s cloud-based analytics provide flexibility to biopharma companies and payers looking for consistent output while deploying a variety of devices across […]
LivaNova Reports Second Quarter 2019 Results
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended June 30, 2019. For the second quarter of 2019, worldwide sales from continuing operations were $277.2 million, a decrease of 3.6 percent on a reported basis and a decrease of 1.0 percent […]
BioTelemetry, Inc. Reports Second Quarter 2019 Financial Resu
July 30, 2019 16:05 ET | Source: BioTelemetry, Inc. Exceeds Expectations Achieves Record Revenue and Adjusted EBITDA MALVERN, Pa., July 30, 2019 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported […]
Sensyne Health Signs Collaboration Agreement with Bayer to Accelerate the Development of New Treatments for Cardiovascular Disease using Clinical Artificial Intelligence
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain. Sensyne Health […]
Prix Galien Selects BIOTRONIK’s PK Papyrus Covered Coronary Stent as Award Finalist
LAKE OSWEGO, Ore., July 31, 2019 /PRNewswire/ — BIOTRONIK today announced the company’s PK Papyrus® covered coronary stent system1 has been named a finalist in the 2019 Prix Galien USA Awards Ceremony for Best Medical Technology. PK Papyrus is used in emergency situations to create a physical barrier to seal life-threatening perforated coronary arteries without the need for invasive surgery. In September […]
CryoLife Reports Second Quarter 2019 Financial Results
ATLANTA, July 30, 2019 /PRNewswire/ — Second Quarter and Recent Business Highlights: Total revenues were $71.1 million in the second quarter of 2019, reflecting year over year growth of 4% and a 7% increase on a non-GAAP constant currency basis, both compared to the second quarter of 2018 BioGlue® revenues increased 5%, and 7% on […]
Reflow Medical Enrolls First Patients in DEEPER OUS Spur Stent Trial
San Clemente, Calif., July 30th, 2019–(BUSINESS WIRE) —Reflow Medical, Inc. announces that the first patients have been enrolled in its DEEPER OUS clinical trial using the Temporary Spur Stent System. DEEPER OUS is a 100-patient prospective, non-randomized, multicenter trial designed to assess the safety and efficacy of the Temporary Spur Stent […]
SentreHEART Announces Initial Clinical Use of the LARIAT® with EpiRAIL™ Procedure for Left Atrial Appendage Exclusion
REDWOOD CITY, Calif.–(BUSINESS WIRE)–SentreHEART, Inc., announced it has successfully completed nine First-In-Human procedures utilizing the LARIAT® with EpiRAIL™ at John Paul II hospital in Krakow, Poland. The LARIAT with EpiRAIL is an epicardial-only, percutaneous approach to complete and permanent closure of the left atrial appendage (LAA) in patients with atrial fibrillation […]



